Thursday, July 4, 2013

Intranasal drug delivery disruptor OptiNose signs licensing deal for migraine treatment

And maybe we'll finally get enough exposure to the nasal drug delivery route that our doctors and researchers can use to bypass the blood brain barrier.
We have to point out this possibility to our doctors, we're 7 million strong and eventually our doctors will realize that we actually know more than they do.
http://medcitynews.com/2013/07/intranasal-drug-delivery-disruptor-optinose-signs-licensing-deal-for-migraine-treatment/?utm_source=MedCity+News+Subscribers&utm_campaign=ff607c7578-RSS_Daily+Top+Stories&utm_medium=email&utm_term=0_c05cce483a-ff607c7578-67013357
 A few paragraphs,  more at link.
Longterm, OptiNose sees its approach to drug delivery as improving treatment for central nervous system disorders because of the possibility its technology could be used to overcome the blood brain barrier, according to its website. It also believes its technology could be sued for vaccines.
Greg Flesher, senior vice president of corporate development of Avanir Pharmaceuticals said in a company statement: “OptiNose has developed a unique device that has the potential to transform the clinical profile of the leading migraine drug, resulting in a new product candidate that we believe can significantly improve upon the current treatment options.”

No comments:

Post a Comment